Next Article in Journal
Reevaluating Patient Eligibility for Inotuzumab Ozogamicin Based on CD22 Expression: Is Dim Expression Sufficient?
Previous Article in Journal
Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report
Article

Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response

1
Section of Hematology/Oncology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1R9, Canada
2
CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada
3
Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada
4
Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada
*
Author to whom correspondence should be addressed.
First and second authors are co-first authors.
Curr. Oncol. 2021, 28(1), 233-251; https://doi.org/10.3390/curroncol28010026
Received: 13 November 2020 / Revised: 22 December 2020 / Accepted: 22 December 2020 / Published: 31 December 2020
Background: COVID-19 has spread rapidly, requiring health delivery systems to undertake dramatic transformations. To evaluate these system changes, we undertook one of the first Canadian health delivery system reviews and the first Canadian cancer centre evaluation of pandemic system modifications. Methods: Questionnaires were distributed to the Canadian Association of Provincial Cancer Agencies (CAPCA) members in order to assess changes to cancer centre services and patient management. Documentation relating to COVID-19 from the CAPCA electronic space was accessed, and all publicly available cancer centre documentation related to COVID-19 was reviewed. Results: Seven provinces completed the questionnaire and had documentation available from the CAPCA electronic space. All screening programs across Canada were suspended. In most provinces surveyed, ≥50% of outpatient appointments were occurring virtually, with <25% using video platforms. Generally, the impact on diagnostic imaging and new patient referrals correlated with the impact of COVID-19. Most provinces had a reduction in operating room availability, with chemotherapy and radiation treatments continuing. Public health modification, including personal protective equipment and screening staff, varied across the country. Conclusion: Canadian cancer centres underwent a rapid and aggressive transformation of services in response to COVID-19, with many similarities and differences across provinces. In part, this response was facilitated by communication under a national association, which in Canada remains unique to cancer. This response may serve to inform changes in other jurisdictions or disease states now and in future waves of the pandemic, as well as a record of changes for future health services and patient outcome research. View Full-Text
Keywords: coronavirus; COVID-19; health service research; healthcare delivery; operations; pandemic; oncology; public health practices; treatment; telemedicine coronavirus; COVID-19; health service research; healthcare delivery; operations; pandemic; oncology; public health practices; treatment; telemedicine
MDPI and ACS Style

Rittberg, R.; Mann, A.; Desautels, D.; Earle, C.C.; Navaratnam, S.; Pitz, M. Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response. Curr. Oncol. 2021, 28, 233-251. https://doi.org/10.3390/curroncol28010026

AMA Style

Rittberg R, Mann A, Desautels D, Earle CC, Navaratnam S, Pitz M. Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response. Current Oncology. 2021; 28(1):233-251. https://doi.org/10.3390/curroncol28010026

Chicago/Turabian Style

Rittberg, Rebekah, Anmol Mann, Danielle Desautels, Craig C. Earle, Sri Navaratnam, and Marshall Pitz. 2021. "Canadian Cancer Centre Response to COVID-19 Pandemic: A National and Provincial Response" Current Oncology 28, no. 1: 233-251. https://doi.org/10.3390/curroncol28010026

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop